RBC Europe’s Microbot Medical MBOT Stock Holding History

RBC Europe’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	-$7	–	926
2021 Q3	$7	Hold	1	–	–	﹤0.01%	1234
2021 Q2	$8	Hold	1	–	–	﹤0.01%	1226
2021 Q1	$9	Hold	1	–	–	﹤0.01%	1175
2020 Q4	$7	Hold	1	–	–	﹤0.01%	1151
2020 Q3	$8	Hold	1	–	–	﹤0.01%	1096
2020 Q2	$7	Hold	1	–	–	﹤0.01%	1064
2020 Q1	$6	Hold	1	–	–	﹤0.01%	1041
2019 Q4	$10	Hold	1	–	–	﹤0.01%	1048
2019 Q3	$5	Hold	1	–	–	﹤0.01%	1052
2019 Q2	$5	Hold	1	–	–	﹤0.01%	1067
2019 Q1	$8	Hold	1	–	–	﹤0.01%	1079
2018 Q4	$2	Hold	1	–	–	﹤0.01%	1096
2018 Q3	$8	Buy	+1	New	+$9	﹤0.01%	1130
2018 Q2	–	Hold	0	–	–	–	1144
2018 Q1	–	Hold	0	–	–	–	1125
2017 Q4	–	Hold	0	–	–	–	1136
2017 Q3	–	Hold	0	–	–	–	1136

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $100M AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RBC Europe's MBOT Position: Q4 2021 in Review

RBC Europe sold out of Microbot Medical (MBOT) in Q4 2021, closing a stake of 1 share — an estimated $7 sold.

RBC Europe first reported a position in MBOT in Q3 2018 and held it in 13 quarters. The position peaked at $10 in Q4 2019. 27 funds tracked by Wall St. Rank hold MBOT as of Q4 2021.

RBC Europe reported no remaining Microbot Medical position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 1 Microbot Medical share in Q4 2021, an estimated $7.
RBC Europe first reported a position in Microbot Medical in Q3 2018 and held it in 13 quarters.
RBC Europe's Microbot Medical position peaked at $10 in Q4 2019.
27 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.